Fundraising Fox
Trice Medical
Malvern, US · Founded 2011 · Delaware corporation · 53 employees on LinkedIn · 3 known investors
Find your way into Trice Medical
Sign up to see every warm intro you have to Trice Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Trice Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Trice Medical develops minimally invasive medical devices, including ultrasonic tenotomy systems for percutaneous tissue removal (treating tendinopathy, calcific tendonitis, and bone spurs), endoscopic carpal tunnel and ligament release systems, diabetic foot ulcer procedure tools, and portable high-resolution arthroscopy. The products are intended for use by clinicians performing minimally invasive orthopedic and wound-care procedures.
Founders & leadership
Trice Medical was founded in 2011 by Jeffrey O'Donnell.
JO
Jeffrey O'DonnellFounder
MF
Mark FosterPresident and Chief Executive Officer2019–2023Mark Foster has spent 25 years in medical technology, including leadership of a $600M business unit at a global company and CEO roles at two venture-backed medical device firms, where he managed R&D, regulatory affairs, manufacturing, and commercial functions. He previously served as head of a $130M business at Smith & Nephew and was the US commercial lead for a $1.5B acquisition.
RK
Richard KienzleExecutiveRichard Kienzle is a founder and former Executive Vice President of Global Sales and Marketing at Globus Medical (2003–2011), where he oversaw sales, marketing, and commercial operations. Prior to Globus, he held roles as Area Vice President at Synthes Spine and National Business Director at United States Surgical Corp, and holds a Bachelor of Arts from Denison University.
Board
AD
Alan DavisBoard director
RS
GK
Gary KurtzmanBoard director
MS
Michael SchraubenBoard director
PK
Puneet KhannaBoard director
VP
Vasant PadmanabhanBoard director
SA
Steve AlmanyBoard director
Investors · 3
BioStar VenturesreportedPetoskey
How we know: funding news · Not right? Tell us
HealthQuest CapitalreportedRedwood City
How we know: funding news · Not right? Tell us
Also in the syndicate · 1
Bioventus Inc.lead
Reported raises · per SEC filings
Form D private placements$123.2M disclosed across 9 rounds · 2012–2023
▶$10.5MraisedAug 2023 · 2 investors · Other Health CareRule 506(b)
▶$10.5MraisedAug 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- NIMESH SHAHDirector
- CHAD NORMANDirector
- MICHAEL STEENExecutive Officer, Director
- Offering amount
- $17.5M
- Amount sold
- $10.5M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.3MraisedOct 2022 · 209 investors · Other Health CareRule 506(b)
▶$7.3MraisedOct 2022 · 209 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- ALAN DAVISDirector
- ERIC C. SALZMANDirector
- MICHAEL SCHRAUBENDirector
- MARK FOSTERExecutive Officer, Director
- VASANT PADMANABHANDirector
- CHRIS YAMAMOTODirector
- RANDY SCOTTDirector
- Offering amount
- $7.3M
- Amount sold
- $7.3M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$27.6MraisedSep 2021 · 39 investors · Other Health CareRule 506(b)
▶$27.6MraisedSep 2021 · 39 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael SchraubenDirector
- Randy ScottDirector
- Mark FosterExecutive Officer, Director
- Alan DavisDirector
- Gary KurtzmanDirector
- Vasant PadmanabhanDirector
- Chris YamamotoDirector
- Offering amount
- $37.6M
- Amount sold
- $27.6M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.2MraisedApr 2021 · 22 investors · Other Health CareRule 506(b)
▶$10.2MraisedApr 2021 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alan DavisDirector
- Randy ScottDirector
- Mark FosterExecutive Officer, Director
- Vasant PadmanabhanDirector
- Gary KurtzmanDirector
- Michael SchraubenDirector
- Offering amount
- $11M
- Amount sold
- $10.2M
- Minimum investment
- $1
- Proceeds to insiders
- $500K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedMar 2020 · 8 investors · Other Health CareRule 506(b)
▶$2.1MraisedMar 2020 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alan DavisDirector
- Randy ScottDirector
- Vasant PadmanabhanDirector
- Michael SchraubenDirector
- Craig K. CarraExecutive Officer
- Gary KurtzmanDirector
- Mark FosterExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $2.1M
- Minimum investment
- $1
- Proceeds to insiders
- $700K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40.6MraisedJan 2019 · 47 investors · Other Health CareRule 506(b)
▶$40.6MraisedJan 2019 · 47 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William A. HawkinsDirector
- Randy ScottDirector
- Mark FosterExecutive Officer
- Vasant PadmanabhanDirector
- Gary KurtzmanDirector
- Mark SchraubonDirector
- Alan DavisDirector
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- Craig CarraExecutive Officer
- Offering amount
- $42.3M
- Amount sold
- $40.6M
- Minimum investment
- $1
- Finders' fees
- $250K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedDec 2016 · 5 investors · Other Health CareRule 506(b)
▶$5MraisedDec 2016 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard WashburnExecutive Officer
- Gary KurtzmanDirector
- Craig CarraExecutive Officer
- William A. HawkinsDirector
- Steve AlmanyDirector
- Garheng KongDirector
- Jeffrey F. O'DonnellExecutive Officer, Director
- Mark FosterExecutive Officer
- Offering amount
- $6.3M
- Amount sold
- $5M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18.1MraisedJan 2015 · 30 investors · Other Health CareRule 506(b)
▶$18.1MraisedJan 2015 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard KienzleDirector
- Richard WashburnExecutive Officer
- Garheng KongDirector
- Jeffrey O'DonnellExecutive Officer, Director
- Craig CarraExecutive Officer
- Steve AlmanyDirector
- Gary KurtzmanDirector
- Offering amount
- $18.1M
- Amount sold
- $18.1M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Trice Medical went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Trice Medical.
In the news
Frequently asked questions
- What does Trice Medical do?
- Trice Medical develops minimally invasive medical devices, including ultrasonic tenotomy systems for percutaneous tissue removal (treating tendinopathy, calcific tendonitis, and bone spurs), endoscopic carpal tunnel and ligament release systems, diabetic foot ulcer procedure tools, and portable high-resolution arthroscopy. The products are intended for use by clinicians performing minimally invasive orthopedic and wound-care procedures.
- Who founded Trice Medical?
- Trice Medical was founded by Jeffrey O'Donnell in 2011.
- Who are Trice Medical's investors?
- Trice Medical's investors include BioStar Ventures, HealthQuest Capital.
- How much funding has Trice Medical raised?
- Trice Medical has disclosed $123.2M raised across 9 rounds.
- Where is Trice Medical headquartered?
- Trice Medical is headquartered in Malvern, US.